Clinical Trials Logo

Clinical Trial Summary

Safety and feasibility study investigating brain biopsy in severe head injury. When a patient undergoes craniotomy or ICP bolt insertion for trauma, a biopsy of brain tissue is taken. Blood, saliva, urine and faeces samples are also taken for 7 days following the brain biopsy. CSF is collected if a CSF drainage device is used.

Clinical Trial Description

A minor amendment was submitted to allow histological and immunohistochemical analysis of the samples. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05206760
Study type Observational
Source Queen Mary University of London
Status Completed
Start date July 15, 2020
Completion date May 16, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05833568 - Five-day 20-minute 10-Hz tACS in Patients With a Disorder of Consciousness N/A
Recruiting NCT04331392 - Online Memory Intervention for Individuals With Traumatic Brain Injury N/A
Recruiting NCT05038930 - Mobilising Patients With Severe Brain Injury in Intensive Care N/A
Completed NCT03810222 - A Prospective Outcome Study in Patients With Moderate to Severe Traumatic Brain Injury
Recruiting NCT04945213 - Biperiden Trial for Epilepsy Prevention Phase 3
Recruiting NCT05048966 - Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons N/A
Recruiting NCT05778110 - Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue